LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the Savara Early Access ...

New offering will support employee mental health and well-being across a broad spectrum of needs—from everyday work-life challenges to complex mental health conditions NEW YORK, July 15, 2025 (GLOBE ...

First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients Provided by GlobeNewswire Apr 8, 2025 4:00pm ...

An expanded access program (EAP) provides patients and healthcare professionals with access to experimental pharmaceuticals that have been pre-approved for usage outside of clinical trials. Patients ...

NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, has extended the duration of the expanded ...

Written in collaboration with Greg Wells. The increase of work-related stress and burnout has reached critical mass, as evidenced by the war on talent, languishing, burnout, job ghosting, and ...

Employee assistance programs (EAPs) are widely regarded as valuable resources that benefit both employees and employers by promoting mental health, improving productivity and reducing workplace ...

LA JOLLA, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...

Teladoc Health is launching a new employee assistance program called Wellbound, which it said is designed to promote a healthier and more engaged workforce. The new EAP, purpose-built for the ...

LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...